tiprankstipranks
Trending News
More News >
Luye Pharma Group Ltd. (HK:2186)
:2186
Hong Kong Market

Luye Pharma Group (2186) Financial Statements

Compare
1 Followers

Luye Pharma Group Financial Overview

Luye Pharma Group's market cap is currently $14.34B. The company's EPS TTM is HK$0.0217441884; its P/E ratio is 25.37; Luye Pharma Group is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is HK$0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 6.06B¥ 6.14B¥ 5.98B¥ 5.20B¥ 5.54B
Gross Profit¥ 4.04B¥ 4.20B¥ 4.14B¥ 3.40B¥ 3.99B
Operating Income¥ 1.15B¥ 887.44M¥ 1.21B¥ 386.99M¥ 1.42B
EBITDA¥ 1.79B¥ 2.08B¥ 1.81B¥ 906.88M¥ 1.88B
Net Income¥ 471.89M¥ 532.61M¥ 604.81M¥ -144.78M¥ 706.59M
Balance Sheet
Cash & Short-Term Investments¥ 6.50B¥ 6.11B¥ 5.54B¥ 5.51B¥ 5.41B
Total Assets¥ 29.61B¥ 25.49B¥ 24.25B¥ 22.58B¥ 20.63B
Total Debt¥ 10.32B¥ 8.42B¥ 9.10B¥ 9.49B¥ 9.98B
Net Debt¥ 5.38B¥ 5.18B¥ 6.78B¥ 7.05B¥ 6.12B
Total Liabilities¥ 13.86B¥ 11.96B¥ 13.21B¥ 13.47B¥ 12.53B
Stockholders' Equity¥ 14.15B¥ 12.53B¥ 10.18B¥ 8.49B¥ 7.89B
Cash Flow
Free Cash Flow¥ 0.00¥ 430.23M¥ 490.14M¥ -1.36B¥ -486.43M
Operating Cash Flow¥ 0.00¥ 1.60B¥ 1.65B¥ 182.37M¥ 1.03B
Investing Cash Flow¥ 0.00¥ -1.42B¥ -1.66B¥ -3.44B¥ 138.20M
Financing Cash Flow¥ 0.00¥ 841.60M¥ 54.15M¥ 1.88B¥ 253.98M
Currency in CNY

Luye Pharma Group Earnings and Revenue History

Luye Pharma Group Debt to Assets

Luye Pharma Group Cash Flow

Luye Pharma Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis